Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03473795 · ClinicalTrials.gov registry record

Developing Non-Communicable Disease Registries in Africa : A Step Towards Providing Quality Data for Improving Patient Outcomes

A clinical trial of Non-Communicable Disease, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
6,990
Enrollment target
14
Study locations

NCT03473795 is a study of Non-Communicable Disease that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 6,990 participants. The trial reports 14 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03473795, a study of Non-Communicable Disease, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
6,990 participants
Enrollment target
14
Study locations

Study Summary

This umbrella protocol seeks to develop robust data registries for non-communicable diseases (NCDs) in sub-Saharan Africa (SSA) with the aim of providing accurate and comprehensive data for the evaluation of such diseases in sub-Saharan African countries.Healthy volunteers will be included in the study for comparison. Additionally, the investigators aim to describe the gut microbiome community diversity of a cohort of community dwelling Nigerians and compare with CRC patients in Nigerian and at MSK. We will collect stool for microbiome and metabolomic analysis from community dwelling persons in the catchment area of ARGO facilities in Nigeria while contemporaneously administering an extensive medical and environmental exposure questionnaire.

Conditions Studied

Interventions

  • BEHAVIORAL Questionnaire forms
  • OTHER Bio-specimen samples

Study Locations (14)

Other

  • University Of Nigeria Teaching Hospital (UNTH) Ituku-Ozalla Enugu - Enugu
  • Lagos State University Teaching Hospital - Ikeja
  • Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC) - Ile-Ife
  • University of Ilorin Teaching Hospitals - Ilorin
  • University of Maiduguri Teaching Hospital (Data collection only) - Maiduguri
  • Ondo State Trauma and Surgical Centre - Ondo
  • Federal Medical Centre Owo - Owo

Oyo State

  • University College Hospital - Ibadan
  • Ladoke Akintola University of Technology - Ogbomoso

New York

  • Memorial Sloan Kettering Cancer Center - New York

Central Business District

  • National Hospital of Abuja (Data collection only) - Abuja

Lagos

  • Lagos State University Teaching Hospital - Idi Araba

Ogun State

  • Olabisis Onabanjo University Teaching Hospital - Sagamu

Ondo State

  • Federal Medical Centre Owo - Owo

Trial Details

FieldValue
Enrollment Target 6,990 participants
Start Date 2018-03-16
Est. Completion 2027-03

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT03473795

The ClinicalTrials.gov registry entry for NCT03473795 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 6,990 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Non-Communicable Disease appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire forms is the first listed.

NCT03473795 reports 14 study locations spanning 7 distinct geographic areas - top geographies include Other, Oyo State, New York.

Frequently Asked Questions

What is clinical trial NCT03473795 about?

NCT03473795 is a clinical study titled "Developing Non-Communicable Disease Registries in Africa : A Step Towards Providing Quality Data for Improving Patient Outcomes". This umbrella protocol seeks to develop robust data registries for non-communicable diseases (NCDs) in sub-Saharan Africa (SSA) with the aim of providing accurate and comprehensive data for the evaluation of such diseases in sub-Saharan African countries.Healthy volunteers will be included in the st...

What is the current status of trial NCT03473795?

This trial is currently active not recruiting. The enrollment target is 6,990 participants. The study started on 2018-03-16. Estimated completion is 2027-03.

What conditions does trial NCT03473795 study?

This clinical trial studies the following conditions: Non-Communicable Disease.

What interventions are being tested in trial NCT03473795?

The interventions under investigation include: Questionnaire forms (BEHAVIORAL), Bio-specimen samples (OTHER).

Who is sponsoring clinical trial NCT03473795?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03473795 being conducted?

This trial has 14 study locations across New York, Central Business District, Lagos, Ogun State, Ondo State. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.